Halozyme Therapeutics
HALO
#2053
Rank
โ‚ฌ6.92 B
Marketcap
56,24ย โ‚ฌ
Share price
0.28%
Change (1 day)
46.49%
Change (1 year)

Revenue for Halozyme Therapeutics (HALO)

Revenue in 2024 (TTM): โ‚ฌ0.94 Billion

According to Halozyme Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.93 Billion. an increase over the revenue in the year 2023 that were of โ‚ฌ0.75 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Halozyme Therapeutics from 2002 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ0.97 B30.07%
2023 โ‚ฌ0.75 B21.9%
2022 โ‚ฌ0.61 B57.21%
2021 โ‚ฌ0.39 B79.93%
2020 โ‚ฌ0.21 B24.35%
2019 โ‚ฌ0.17 B31.8%
2018 โ‚ฌ0.13 B-49.69%
2017 โ‚ฌ0.26 B89.21%
2016 โ‚ฌ0.13 B12.9%
2015 โ‚ฌ0.12 B99.41%
2014 โ‚ฌ61.94 M56.1%
2013 โ‚ฌ39.68 M24.01%
2012 โ‚ฌ31.99 M-25.91%
2011 โ‚ฌ43.18 M321.65%
2010 โ‚ฌ10.24 M7.34%
2009 โ‚ฌ9.54 M52.21%
2008 โ‚ฌ6.26 M140.91%
2007 โ‚ฌ2.6 M249.75%
2006 โ‚ฌ0.74 M
2003 โ‚ฌ0.01 M-83.21%
2002 โ‚ฌ0.08 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.24 B-73.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ41.48 B 4,336.29%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ12.88 B 1,277.69%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ55.36 B 5,820.38%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ44.17 B 4,623.65%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ81.80 B 8,648.04%๐Ÿ‡บ๐Ÿ‡ธ USA